Works matching IS 10781552 AND DT 2021 AND VI 27 AND IP 3


Results: 37
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15

    Tocilizumab as salvage treatment of refractory pulmonary acute graft-versus-host disease.

    Published in:
    Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 3, p. 751, doi. 10.1177/1078155220948934
    By:
    • Melgarejo-Ortuño, Alejandra;
    • Escudero-Vilaplana, Vicente;
    • Revuelta-Herrero, Jose Luis;
    • Bailen, Rebeca;
    • Collado-Borrell, Roberto;
    • Gomez-Centurión, Ignacio;
    • Oarbeascoa, Guillen;
    • Kwon, Mi;
    • Herranz-Alonso, Ana;
    • Diez-Martin, Jose Luis;
    • Sanjurjo-Saez, Maria
    Publication type:
    Article
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31

    Predictors of increased melphalan exposure correlate with overall survival, nonrelapse mortality, and toxicities in patients undergoing reduced-intensity allogeneic stem cell transplantation with fludarabine and melphalan.

    Published in:
    Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 3, p. 579, doi. 10.1177/1078155220927436
    By:
    • Sweiss, Karen;
    • Calip, Gregory Sampang;
    • Holden, Jaime;
    • Lewkowski, Paulina;
    • Mialik, Iryna;
    • Johnson, Jeremy;
    • Galvin, John P;
    • Rondelli, Damiano;
    • Patel, Pritesh
    Publication type:
    Article
    32
    33
    34
    35
    36
    37